Target type: biologicalprocess
The process of introducing one or more phosphate groups into a lipid, any member of a group of substances soluble in lipid solvents but only sparingly soluble in aqueous solvents. [GOC:bf, ISBN:0198506732]
Lipid phosphorylation is a crucial biological process that involves the addition of a phosphate group (PO43-) to a lipid molecule. This modification dramatically alters the lipid's properties, impacting its interactions with other molecules and its role in cellular processes.
Here's a detailed breakdown:
**1. Enzymes Involved:**
- **Kinases:** These enzymes catalyze the transfer of a phosphate group from a donor molecule (typically ATP) to the lipid.
- **Phosphatases:** These enzymes reverse the phosphorylation process by removing the phosphate group from the lipid.
**2. Types of Lipids Phosphorylated:**
- **Glycerophospholipids:** These are major components of cell membranes and are often phosphorylated at the head group, modifying their charge and interactions with other molecules.
- **Sphingolipids:** These are also found in cell membranes and can be phosphorylated at the head group, playing a role in cell signaling and membrane organization.
**3. Biological Significance:**
- **Membrane Structure and Dynamics:** Phosphorylation can alter the charge and hydrophilicity of lipids, affecting their packing and interactions with other membrane components.
- **Cell Signaling:** Phosphorylated lipids act as second messengers in various signaling pathways, relaying information from the cell surface to the interior.
- **Cellular Trafficking:** Phosphorylation can regulate the movement of lipids within cells, directing them to specific locations or influencing their interactions with transport proteins.
- **Enzyme Activity:** Phosphorylation can activate or inhibit the activity of enzymes involved in lipid metabolism, regulating the synthesis, breakdown, and modification of lipids.
- **Disease Processes:** Dysregulation of lipid phosphorylation is linked to various diseases, including cancer, neurodegenerative disorders, and metabolic syndromes.
**4. Specific Examples:**
- **Phosphatidylinositol (PI) signaling:** Phosphorylation of PI at different positions generates various phosphoinositides, acting as second messengers in signaling pathways.
- **Sphingomyelin phosphorylation:** Phosphorylation of sphingomyelin is involved in regulating membrane fluidity and cell growth.
Overall, lipid phosphorylation is a fundamental process that profoundly affects cellular function and contributes to a wide range of biological processes.'
"
Protein | Definition | Taxonomy |
---|---|---|
Diacylglycerol kinase alpha | A diacylglycerol kinase alpha that is encoded in the genome of human. [PRO:DNx, UniProtKB:P23743] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
r 59022 | R 59022: diacylglycerol kinase inhibitor; structure given in first source; platelet activator factor antagonist | diarylmethane | |
dioctanoyl ethylene glycol | |||
ritanserin | ritanserin : A thiazolopyrimidine that is 5H-[1,3]thiazolo[3,2-a]pyrimidin-5-one which is substituted at position 7 by a methyl group and at position 6 by a 2-{4-[bis(4-fluorophenyl)methylidene]piperidin-1-yl}ethyl group. A potent and long-acting seratonin (5-hydroxytryptamine, 5-HT) antagonist of the subtype 5-HT2 (Ki = 0.39 nM), it is used in the treatment of a variety of disorders including anxiety, depression and schizophrenia. It has little sedative action. Ritanserin: A selective and potent serotonin-2 antagonist that is effective in the treatment of a variety of syndromes related to anxiety and depression. The drug also improves the subjective quality of sleep and decreases portal pressure. | organofluorine compound; piperidines; thiazolopyrimidine | antidepressant; antipsychotic agent; anxiolytic drug; dopaminergic antagonist; EC 3.4.21.26 (prolyl oligopeptidase) inhibitor; serotonergic antagonist |
cochlioquinone a | cochlioquinone A: from Helminthosporium sativum; competitive inhibitor of ivermectin binding; RN from Chem Abstract Index Guide 1990; structure given in first source | oxanes | |
r 59949 | R 59949: diacylglycerol kinase inhibitor | diarylmethane | |
1-monooleoyl-rac-glycerol | 1-oleoylglycerol : A 1-monoglyceride where the acyl group is oleoyl. monooleoylglycerol : A monoglyceride in which the acyl group is oleoyl with the position of acylation unspecified. Peceol: lipid excipient containing readily dispersible mixture of mono- & diglycerides of oleic acid | 1-acylglycerol 18:1; monooleoylglycerol | plant metabolite |
stemphone | stemphone: structure given in first source |